Home
About Atom
Management Team
Advisory Board
Investors
Our Programs
Pipeline
Gout & Hyperuricemia
Acute Gout
News & Events
Contact Us
Post navigation
Previous Post
Atom Bioscience completes about $30 million in Series B financing
Next Post
Atom Bioscience to Present at Biotech Showcase January 10-12, 2022